Pharma Inc gets back to life beyond Covid

August 1, 2022

For Sun Pharma, its investment in speciality business is paying off, as it is becoming a driver of growth for the company’s US business. Cipla’s ‘One India’ strategy, focusing on branded prescription, trade generics and consumer health brands, is leading to continued core portfolio momentum across businesses.

More To Explore

Ahead of Market: 10 things that will decide stock market action on Monday

Indian markets tumbled on Friday, mirroring global anxieties over the US Federal Reserve’s projected slower rate cuts. Heavy selling in financial and IT stocks pushed

December 22, 2024

Year-ender 2024: FII selling crosses Rs 1 lakh crore in 2 sectors. Will 2025 see a U-turn?

Foreign Portfolio Investors (FPIs) focused on selling financials and oil & gas stocks in 2024, resulting in significant sectoral outflows. Outlook for 2025 suggests moderate

December 22, 2024

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003